Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-20

Clinical Trial Update: Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating repeat administration of Ad/PNP and Fludarabine Phosphate in patients with head and neck cancer. The study has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ad/PNP
  • Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: GeoVax, Inc. | Conditions: Recurrent Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-20